Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Preferential binding of vasoactive intestinal peptide to hepatic nonparenchymal cells

Journal Article · · Am. J. Physiol.; (United States)
OSTI ID:5079857
The binding of /sup 125/I-vasoactive intestinal peptide (/sup 125/I-VIP) and /sup 125/I-insulin has been examined in highly enriched populations of rat hepatocytes and hepatic nonparenchymal cells. /sup 125/I-VIP bound to high-affinity sites (Ka = 1.7 X 10(9) M-1) in nonparenchymal cells. Specific binding in these cells was nearly fivefold greater than in hepatocytes (15.0 +/- 0.6% vs. 3.6 +/- 0.7% radioactivity bound per 4 X 10(5) cells). In contrast, /sup 125/I-insulin binding was similar in both cell populations (18.2 +/- 2.4% per 4 X 10(5) cells in hepatocytes vs. 17.1 +/- 1.0% in nonparenchymal cells). Glucagon and insulin had no effect on /sup 125/I-VIP binding in nonparenchymal cells. Secretin inhibited /sup 125/I-VIP binding but was only about 1% as potent as unlabeled VIP. VIP had no apparent effect on cAMP levels in either cell population, whereas glucagon increased cAMP levels in both cell types. These findings suggest that VIP binds preferentially to hepatic nonparenchymal cells and that these cells are primarily responsible for the clearance of VIP from the portal circulation.
OSTI ID:
5079857
Journal Information:
Am. J. Physiol.; (United States), Journal Name: Am. J. Physiol.; (United States); ISSN AJPHA
Country of Publication:
United States
Language:
English